Previous work showed that several relatively specific inhibitors of neurona
l nitric oxide synthase (nNOS) produce protection against MPTP induced dopa
minergic toxicity. We examined whether a highly specific novel inhibitor of
nNOS, ARR1 7338, could also protect against MPTP toxicity. ARR17338 produc
ed dose-dependent significant protection against MPTP induced depletion of
dopamine and protected against MPTP induced depletions of tyrosine hydroxyl
ase immunostained neurons in the substantia nigra. These results provide fu
rther evidence that inhibitors of nNOS may be useful for the treatment of P
arkinson's disease. NeuroReport 11:1265-1268 (C) 2000 Lippincott Williams &
Wilkins.